Crossmark

Systemic immune-inflammatory index predict short-term outcome in recurrent/metastatic and locally advanced cervical cancer patients treated with PD-1 inhibitor

Crossref DOI link: https://doi.org/10.1038/s41598-024-82976-6

Published Online: 2024-12-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Qingqing

Zhai, Baoqian

Li, Jingjing

Wang, Hui

Liu, Zhengcao

Shi, Runjun

Wu, Haohao

Xu, Yingying

Ji, Shengjun
License Information

Text and Data Mining valid from 2024-12-28

Version of Record valid from 2024-12-28
More Information

Article History

Received: 26 June 2024

Accepted: 10 December 2024

First Online: 28 December 2024

Declarations

:

: The authors declare no competing interests.

: This study was approved by the ethical committee of The Affiliated Suzhou Hospital of Nanjing Medical University and Yancheng City No.1 People’s Hospital.

Document is current

Any future updates will be listed below